U.S. Artificial Ventilation And Anesthesia Masks Market Size & Trends
The U.S. artificial ventilation and anesthesia masks market size was estimated at USD 552.7 million in 2024 and is projected to grow at a CAGR of 4.7% from 2025 to 2030. The growth can be attributed to the rising incidences of respiratory diseases, development in technology, rising number of surgeries, population growth, especially of the geriatric people, effects of the COVID-19 pandemic, increased healthcare spending, and support in the policies.
The rising prevalence of chronic respiratory diseases such as COPD, asthma, and pneumonia will drive market growth. According to the CDC report of June 2024, around 6 million adults in the U.S. have COPD, and it is one of the top 10 causes of death in the U.S., presenting a significant opportunity for healthcare providers and manufacturers to invest in respiratory care solutions. The increasing demand for long-term home care and emergency treatment for lung diseases in adults and children will also contribute to market demand.
Advancements in technology have led to the development of more user-friendly and efficient artificial ventilation and anesthesia masks. Features such as integrated monitoring systems for disposables, improved mask designs for enhanced patient comfort, and enhanced safety features are attracting healthcare providers to these products. Moreover, as the demand for high-quality respiratory care solutions increases, manufacturers are investing in research and development to create innovative products that meet the evolving needs of healthcare professionals. With a focus on patient comfort, safety, and efficacy, the artificial ventilation and anesthesia masks market is poised for significant growth in the coming years.
The COVID-19 pandemic greatly impacted the U.S. artificial ventilation and anesthesia masks market, driving a surge in demand for respiratory support equipment due to the high incidence of severe respiratory complications. Hospitals and emergency departments faced acute shortages of ventilators and associated consumables, including masks, prompting rapid production scale-ups and emergency use authorizations by the FDA. The crisis accelerated the adoption of single-use and disposable masks to reduce cross-contamination risks and spurred innovations in non-invasive ventilation technologies. Additionally, supply chain disruptions and raw material shortages exposed vulnerabilities, leading to increased domestic manufacturing initiatives and stockpiling strategies post-pandemic.
U.S. Artificial Ventilation And Anesthesia Masks Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the U.S. artificial ventilation and anesthesia masks market report based on mask type and application:Mask Type Outlook (Revenue, USD Million, 2018 - 2030)
- Disposable Masks
- Reusable Masks
Application Outlook (Revenue, USD Million, 2018 - 2030)
- Operating Rooms
- ICU
- Emergency Rooms
- Home Care
- ASCs
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Variables, Trends, & Scope
Chapter 4. U.S. Artificial Ventilation and Anesthesia Masks Market: Type Estimates & Trend Analysis
Chapter 5. U.S. Artificial Ventilation and Anesthesia Masks Market: Application Estimates & Trend Analysis
Chapter 6. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Medtronic
- BD (Becton, Dickinson and Company)
- ResMed
- Vyaire Medical, Inc.
- Thermo Fisher Scientific Inc.
- Drägerwerk AG & Co. KGaA
- Koninklijke Philips N.V.
- Nihon Kohden Corporation
- Hamilton Medical
- Ambu A/S
- Cardinal Health
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 90 |
| Published | June 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 552.7 Million |
| Forecasted Market Value ( USD | $ 727.3 Million |
| Compound Annual Growth Rate | 4.7% |
| Regions Covered | United States |
| No. of Companies Mentioned | 11 |
